SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:prod.swepub.kib.ki.se:146982983"
 

Sökning: onr:"swepub:oai:prod.swepub.kib.ki.se:146982983" > What Can N-glycomic...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002479naa a2200289 4500
001oai:prod.swepub.kib.ki.se:146982983
003SwePub
008240701s2021 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1469829832 URI
024a https://doi.org/10.3390/biom110608582 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Gaunitz, S4 aut
2451 0a What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?
264 c 2021-06-09
264 1b MDPI AG,c 2021
520 a Proteomics—large-scale studies of proteins—has over the last decade gained an enormous interest for studies aimed at revealing proteins and pathways involved in disease. To fully understand biological and pathological processes it is crucial to also include post-translational modifications in the “omics”. To this end, glycomics (identification and quantification of glycans enzymatically or chemically released from proteins) and glycoproteomics (identification and quantification of peptides/proteins with the glycans still attached) is gaining interest. The study of protein glycosylation requires a workflow that involves an array of sample preparation and analysis steps that needs to be carefully considered. Herein, we briefly touch upon important steps such as sample preparation and preconcentration, glycan release, glycan derivatization and quantification and advances in mass spectrometry that today are the work-horse for glycomics and glycoproteomics studies. Several proteins related to Alzheimer disease pathogenesis have altered protein glycosylation, and recent glycomics studies have shown differences in cerebrospinal fluid as well as in brain tissue in Alzheimer disease as compared to controls. In this review, we discuss these techniques and how they have been used to shed light on Alzheimer disease and to find glycan biomarkers in cerebrospinal fluid.
700a Tjernberg, LOu Karolinska Institutet4 aut
700a Schedin-Weiss, Su Karolinska Institutet4 aut
710a Karolinska Institutet4 org
773t Biomoleculesd : MDPI AGg 11:6q 11:6x 2218-273X
856u https://www.mdpi.com/2218-273X/11/6/858/pdf
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:146982983
8564 8u https://doi.org/10.3390/biom11060858

Hitta via bibliotek

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...
Gaunitz, S
Tjernberg, LO
Schedin-Weiss, S
Artiklar i publikationen
Biomolecules
Av lärosätet
Karolinska Institutet

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy